Sangani Hospitals Ltd vs Syngene International Ltd Stock Comparison
Sangani Hospitals Ltd vs Syngene International Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Sangani Hospitals Ltd is ₹ 59.7 as of 23 Oct 15:30
. The P/E Ratio of Sangani Hospitals Ltd changed from 21.7 on March 2024 to 17.9 on March 2026 . This represents a CAGR of -6.22% over 3 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Sangani Hospitals Ltd changed from ₹ 58.55 crore on March 2024 to ₹ 53.59 crore on March 2026 . This represents a CAGR of -2.91% over 3 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Sangani Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The ebitda of Sangani Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The net profit of Sangani Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN%
The Dividend Payout of Sangani Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .
About Sangani Hospitals Ltd
Sangani Hospitals Limited was incorporated as a Public Limited Company in Keshod, Gujarat on November 11, 2021, through Certificate of Incorporation dated November 12, 2021 and Certificate of Commencement of Business dated December 14, 2021 issued by the Registrar of Companies, Ahmedabad.
Sangani Group is a healthcare organization founded by the Promoter, Dr. Ajaykumar Sangani.
Sangani Hospital is 36 beds multi-speciality hospital with primary, secondary and tertiary care facilities.
Presently, the Company is into the business of Hospitals, pathological laboratory and Pharmacy stores at Keshod and Veraval location in Gujarat.
The Company is a multi-speciality healthcare provider operating in Keshod and Veraval region of Gujarat with a combined bed capacity of 170 beds.
Their services include super speciality services, speciality services and other support services.
About Syngene International Ltd
Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers.
Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.
FAQs for the comparison of Sangani Hospitals Ltd and Syngene International Ltd
Which company has a larger market capitalization, Sangani Hospitals Ltd or Syngene International Ltd?
Market cap of Sangani Hospitals Ltd is 82 Cr while Market cap of Syngene International Ltd is 14,810 Cr
What are the key factors driving the stock performance of Sangani Hospitals Ltd and Syngene International Ltd?
The stock performance of Sangani Hospitals Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Sangani Hospitals Ltd and Syngene International Ltd?
As of October 25, 2026, the Sangani Hospitals Ltd stock price is INR ₹59.7. On the other hand, Syngene International Ltd stock price is INR ₹366.9.
How do dividend payouts of Sangani Hospitals Ltd and Syngene International Ltd compare?
To compare the dividend payouts of Sangani Hospitals Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.